Cargando…

Breast Cancer Clinical Trial of Chemotherapy and Trastuzumab: Potential Tool to Identify Cardiac Modifying Variants of Dilated Cardiomyopathy

Doxorubicin and the ERBB2 targeted therapy, trastuzumab, are routinely used in the treatment of HER2+ breast cancer. In mouse models, doxorubicin is known to cause cardiomyopathy and conditional cardiac knock out of Erbb2 results in dilated cardiomyopathy and increased sensitivity to doxorubicin-ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Serie, Daniel J., Crook, Julia E., Necela, Brian M., Axenfeld, Bianca C., Dockter, Travis J., Colon-Otero, Gerardo, Perez, Edith A., Thompson, E. Aubrey, Norton, Nadine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715703/ https://www.ncbi.nlm.nih.gov/pubmed/29367538 http://dx.doi.org/10.3390/jcdd4020006

Ejemplares similares

The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes
por: Necela, Brian M., et al.
Publicado: (2017)

Dilated cardiomyopathy following trastuzumab chemotherapy
por: Karmakar, Saurabh, et al.
Publicado: (2012)

Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors
por: Norton, Nadine, et al.
Publicado: (2016)

Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer
por: Norton, Nadine, et al.
Publicado: (2018)

Association of Genetic Variants at TRPC6 With Chemotherapy-Related Heart Failure
por: Norton, Nadine, et al.
Publicado: (2020)

Gene Expression, Single Nucleotide Variant and Fusion Transcript Discovery in Archival Material from Breast Tumors
por: Norton, Nadine, et al.
Publicado: (2013)

Sex Differences, Genetic and Environmental Influences on Dilated Cardiomyopathy
por: Jain, Angita, et al.
Publicado: (2021)

Pathophysiological Roles of PPARγ in Gastrointestinal Epithelial Cells
por: Necela, Brian M., et al.
Publicado: (2008)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Clinical characterization and natural history of chemotherapy‐induced dilated cardiomyopathy
por: Lalario, Andrea, et al.
Publicado: (2022)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

Prevalence of Chagas heart disease in dilated cardiomyopathy
por: González-Zambrano, Héctor, et al.
Publicado: (2021)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

Transcriptomics and Beyond in Dilated Cardiomyopathy
por: Cowan, Jason R., et al.
Publicado: (2023)

Calreticulin Induces Dilated Cardiomyopathy
por: Lee, Dukgyu, et al.
Publicado: (2013)

Cardiomyopathy, familial dilated
por: Taylor, Matthew RG, et al.
Publicado: (2006)

Dilated cardiomyopathy in childhood
por: Franklin, OM, et al.
Publicado: (2000)

Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009)

Apoptosis in Dilated Cardiomyopathy
por: Hong, Bum Kee, et al.
Publicado: (2000)

Retrospective study of dilated cardiomyopathy in dogs
por: Freid, Kimberly J., et al.
Publicado: (2020)

Speckle tracking echocardiography in hypokinetic non‐dilated cardiomyopathy: comparison with dilated cardiomyopathy
por: Mombeini, Hoda, et al.
Publicado: (2020)

Histopathological Aspects of the Myocardium in Dilated Cardiomyopathy
por: MITRUT, R., et al.
Publicado: (2018)

Correction: Calreticulin Induces Dilated Cardiomyopathy
por: Lee, Dukgyu, et al.
Publicado: (2013)

Differential Expression of MicroRNAs in Tumors from Chronically Inflamed or Genetic (APC(Min/+)) Models of Colon Cancer
por: Necela, Brian M., et al.
Publicado: (2011)

Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831
por: Pogue-Geile, Katherine L, et al.
Publicado: (2020)

A Case of Trastuzumab-Associated Cardiomyopathy Presenting as an Acute Coronary Syndrome: Acute Trastuzumab Cardiotoxicity
por: Hidalgo, Sylvana, et al.
Publicado: (2013)

Comparative Effectiveness and Safety of Pertuzumab and Trastuzumab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy for Treatment of Metastatic Breast Cancer
por: Dai, Wei Fang, et al.
Publicado: (2022)

Hypoparathyroidism and reversible dilated cardiomyopathy
por: Babu, M. Suresh, et al.
Publicado: (2011)

The Mutations Associated with Dilated Cardiomyopathy
por: Parvari, Ruti, et al.
Publicado: (2012)

Infants with dilated cardiomyopathy and hypocalcemia
por: Sanyal, Debmalya, et al.
Publicado: (2013)

LMNA-related dilated cardiomyopathy
por: Vaikhanskaya, Tatiyana, et al.
Publicado: (2014)

Rhinovirus-associated dilated cardiomyopathy
por: Chow, Jeffrey, et al.
Publicado: (2020)

Myocarditis and idiopathic dilated cardiomyopathy
por: Brown, Charles A., et al.
Publicado: (1995)

Echocardiographic Advances in Dilated Cardiomyopathy
por: Faggiano, Andrea, et al.
Publicado: (2021)

The Genetic Evaluation of Dilated Cardiomyopathy
por: Bui, Quan M., et al.
Publicado: (2023)

Reversible dilated cardiomyopathy caused by hypothyroidism
por: Khochtali, I, et al.
Publicado: (2011)

Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
por: Puckelwartz, Megan J., et al.
Publicado: (2021)

Cushing Syndrome in the Setting of Chronic Dilated Cardiomyopathy: Can Treatment Improve Chronic Dilated Cardiomyopathy?
por: Pathak, Leilani, et al.
Publicado: (2021)

Natural History of Dilated Cardiomyopathy in Children
por: Puggia, Ilaria, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5lukoq2h45i1vpvs15dg9a14up